Biography
Dr Fernando de la Calle is currently the Head of the Microbiology Dpt. within Drug Discovery (R&D) at PharmaMar, biopharma involved in the development and commercialization of anticancer drugs of marine origin. He received his Ph.D. in Molecular Biology from UAM (Madrid) in 1998. He also completed an Executive-MBA at IDE-CESEM (Madrid) in 2005. He has more than 25 years’ experience working in drug discovery from marine microorganisms. He is an Expert in Applied Biotechnology, Molecular characterization of Bacterial Biodiversity and the use of Biotechnology tools for Drug Discovery . Co-author of the current hemisynthetic process for manufacturing the anticancer Yondelis®, the first European marine derived compound approved. In addition, he has been external advisor for biotechnology issues to the Spanish Government (INCUAL), current member of the International Advisory Group of european ERA-NET for Marine Biotechnology and Biodiversity, reviewer for H2020 and ERA-NET projects and the scientific contact person from PharmaMar for FP7/H2020 EU projects related to Marine Biodiversity such as MAMBA, MaCuMBA, MicroB3 and INMARE as WP leader. Principal Investigator in more than 10 other nationally funded projects.
Research Interest
Marine Biotechnology, Drug Discovery from Microorganisms, Microbial Diversity and Genomics, Applied Microbiology.
Biography
Dr. Saleh received the Ph.D. degree from the University of Toronto in 1997. Working at the Department of medical biophysics his work concerned the interaction of bacterial toxins and membranes. Prior to joining the Department of Biology at Laurentian University, I spent time as a postdoctoral fellow at the University of California at Los Angeles (UCLA) and Colorado State University. Dr. Saleh is currently the Chairperson for the Department of Biology at Laurentian University.
Research Interest
The area of my expertise is molecular biophysics. My training in this area has been used in the past 15 years to study various aspects of bacterial physiology and their interactions with their environments. Several research programs were carried out in relation to interaction of bacteria with their environments in both pathogenic and non-pathogenic bacteria. In non-pathogenic bacteria, I used bioinformatics techniques to address certain questions on the process of protein secretion in bacteria. Specifically, how the structural features of signal sequences direct the membrane translocation of signal sequence-containing secretory proteins. I currently have a graduate student looking at the involvement of the mRNA of such secretory proteins in targeting the protein to the membrane for translocation and secretion.
Biography
Dr. E.I.Kalamiyets is a recognized expert in the field of microbial synthesis. Major trends of her research are genesis of biologically active compounds showing antimicrobial and entomopathogenic action, elaboration of biotechnologies aimed at producing novel efficient microbial agents to control crop pests and pathogens. Progress of priority trends in microbiology and biotechnology is fostering food, energy, drug and ecological security of Belarus Republic. Under her supervision and with direct contribution collection of microbial antagonists promising sources of biopesticides and probiotic preparations was founded. Dr. E.I. Kalamiyets deciphered mechanisms controlling interaction of isolated cultures with animal and plant pathogens, established the nature of produced antimicrobial metabolites and proposed original technologies of producing microbial preparations with phytoprotective, disinfecting, growth-and immune-stimulating activities. Vital achievement of Dr. E.I. Kalamiyets is realization of innovative processes and launching of pilot-plant manufacturing of biopesticides Fruitin, Phyroprotectin, Baciturin to control pests and pathologies in plant cultivars at Novopolotsk protein-vitamin concentrate plant and large-scale fabrication of bioconservating agent Lacsil intended for ensiling of vegetable feedstock. Dr. E.I. Kalamiyets is an author of 341 publications, including 2 books, 11 patents. 9 original products and related technologies were scaled up to industrial level, manufactured and commercially distributed at the market. As coordinator of three national research programs, member of State Expert Council on chemical, pharmaceutical and microbiological industries, general director of Scientific and Production association "Chemical synthesis and biotechnologies" functioning within the framework of National Academy of Sciences, Dr. E.I. Kalamiyets is directly contributing into progress of biotechnology in the Republic of Belarus.
Research Interest
Microbiology and Biotechnology